NewsRx

Search our medical news database

AIDS Weekly

Susan Hasty, Publisher

Table of Contents . . . April 12th, 2004

Non-Subscriber - Summaries Only

Related Areas: Other Issues in AIDS Weekly | Other Publications

Drug Development - Novel HIV fusion inhibitor T-1249 safe, effective in early trials

HIV/AIDS Therapy - HIV-infected cells have heightened vulnerability to electrical damage

HIV/AIDS Dyslipidemia - Bone mineral loss frequent in female patients during HAART

HIV/AIDS Neuropathology - Murine spatial learning and long-term potentiation disrupted by HIV Tat

HIV/AIDS Pathogenesis - Thiol/disulfide exchange needed for R4 HIV T-cell fusion during viral entry

Kaposi Sarcoma - Novel immunoassay distinguishes KS from mimics

Atherosclerosis - Heart disease more common, progresses quicker in HIV patients

Business Update - Immtech continued to prepare for commercialization

Disease Transmission - Project aims to develop microbicides to protect women against HIV

Finance - Biotech company loss of $0.05 per share, provides clinical update

Finance - Biotech company reports 2003 net loss of $11.0 million

HIV/AIDS - AIDS conference to mobilize leaders to get drugs to the needy

HIV/AIDS - African delegates meet to plan joint response to AIDS pandemic

HIV/AIDS - Applications submitted for fixed-dose coformulation of Viread and Emtriva

HIV/AIDS - Health Canada official to join global HIV partnership

HIV/AIDS - More government, community involvement needed to tackle Asia AIDS epidemic

HIV/AIDS - Phase I clinical trial initiated for PA-457 oral anti-HIV compound

HIV/AIDS - Retina Rainbow HIV-1 RNA test distributors announced

HIV/AIDS - U.N. report: AIDS threatens China's progress in living standards

HIV/AIDS Awareness - Media coverage of HIV/AIDS decreasing, but focus on global epidemic increasing

HIV/AIDS Cancer - Anti-HHV-8 therapy effective against multicentric Castleman disease

HIV/AIDS Cancer - Bone marrow features in AIDS patients characterized

HIV/AIDS Drug Resistance - Development of indinavir resistance can be insidious

HIV/AIDS Epidemiology - "Dipping" may throw off conventional measures of sexual behavior

HIV/AIDS Epidemiology - HIV rates rising among the elderly

HIV/AIDS Epidemiology - Pacific islands face rapidly expanding HIV epidemic

HIV/AIDS Genomics & Genetics - Effect of within-patient HIV mutation on population-level evolution clarified

HIV/AIDS Genomics & Genetics - Recombination dynamics of HIV genome determined

HIV/AIDS Immune Control - HIV-induced phenotype changes hamstring Gag-specific CD4 cells

HIV/AIDS Immune Control - HIV-infected lymphocytes modulate fibronectin output via TGFbeta1 secretion

HIV/AIDS Immune Control - Interaction between Leishmania and HIV clarified

HIV/AIDS Neuropathology - Effects of HAART on CNS disorders elucidated

HIV/AIDS Policy - Failures of Russian AIDS policy dissected

HIV/AIDS Policy - Politics of AIDS control in Uganda examined

HIV/AIDS Prevention - Gates Foundation provides $47 million for AIDS programs in India

HIV/AIDS Public Health - Participatory action research program has promising results in Philippines

HIV/AIDS RNA Research - Novel base triple identified in HIV TAR hairpin

HIV/AIDS Therapy - Lipid profiles induced by different antiretroviral drugs characterized

HIV/AIDS Tuberculosis - Effects of HIV/TB coinfection of mothers in poor areas clarified

HIV/AIDS Vaccine - AIDS vaccine to be tested on humans

HIV/HBV Coinfection - Treatment for HBV infection in HIV patients reviewed

Heart Disease - Safety study of Lexipafant completed, phase III commences

Infectious Disease - Oral mucosa defends against Candida albicans infection in humans

Kaposi Sarcoma - Inflammatory cytokines may aid KSHV latency

Legal Issues - AIDS care group sues drug company for false advertising

Medical Marijuana - Spokespeople sought to endorse marijuana in variety of medical applications

Personnel - Diagnostics company names Giles Crouch VP marketing & business development

Policy - New report finds UN stance on illicit drugs fuel global HIV infections

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook